Pricing Log in Create free account

Benitec Biopharma Limited (BNTC) vs Contineum Therapeutics, Inc. (CTNM)

Benitec Biopharma Limited and Contineum Therapeutics, Inc. are both Biotechnology companies. Benitec Biopharma Limited and Contineum Therapeutics, Inc. are of similar size ($297.2M and $295.1M). Across the 10 metrics below, Benitec Biopharma Limited leads on 5 and Contineum Therapeutics, Inc. on 5.

Valuation

Metric BNTC CTNM Biotechnology median
P/E n/m n/m 8.50
P/S 5,034.47 n/m 9.71
P/B 2.13 1.10 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 2,636.87 n/m 9.21
Earnings yield (12.08%) (24.64%) (33.15%)
Free cash flow yield (4.40%) (20.33%) (25.50%)

Profitability

Metric BNTC CTNM Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (33.21%) (28.01%) (56.36%)
Return on assets (32.28%) (26.57%) (48.04%)
Return on invested capital 0.00% (1,334.41%) 0.00%

Growth

Metric BNTC CTNM Biotechnology median
Revenue growth (TTM) (1.32%) — 6.02%
EPS growth (last fiscal year) 6.67% 0.46% 30.26%
Revenue growth, 5-year CAGR (54.02%) — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BNTC CTNM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 34.00 37.17 4.72
Net debt to EBITDA 3.52 3.88 0.96

Dividend

Metric BNTC CTNM Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BNTC CTNM Biotechnology median
Market cap 295.08m 297.21m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack